O

ONCOVIDA | Santiago, Chile

Research site
(Unclaimed)
Location
General Holley 2381, Santiago, Región Metropolitana de Santiago, Chile

Site insights

Top conditions

Top treatments

Pembrolizumab
Nivolumab
Fianlimab
MK-7684A
Fulvestrant
Sunitinib
Cabozantinib
Bemarituzumab
Platinum
Belzutifan

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

14 of 15 total trials

A Study of Adjuvant Pembrolizumab/Vibostolimab (MK-7684A) Versus Pembrolizumab for Resected High-Risk Melanoma in Participants With High-Risk Stage II-IV Melanoma (MK-7684A-010/KEYVIBE-010)

The primary purpose of this study is to compare pembrolizumab/vibostolimab to pembrolizumab with respect to recurrence-free survival (RFS). The prima...

Active, not recruiting
Melanoma
Biological: Pembrolizumab/Vibostolimab
Biological: Pembrolizumab

The purpose of this study is to evaluate participant preference for coformulated hyaluronidase/pembrolizumab (MK-3475A) administered subcutaneously (...

Enrolling
Melanoma
Renal Cell Carcinoma
Biological: Pembrolizumab
Biological: Pembrolizumab co-formulated with hyaluronidase
Locations recently updated

This is a Phase III, randomized, open-label multicenter study that will evaluate the efficacy and safety of giredestrant compared with fulvestrant, b...

Enrolling
Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer
Diagnostic Test: FoundationOne Liquid CDx Assay (F1LCDx)
Drug: Giredestrant

This study is researching an experimental drug called REGN3767, also known as fianlimab (R3767), when combined with another medication called cemipli...

Enrolling
Melanoma
Drug: Pembrolizumab
Drug: Placebo

The main objective of Part 1 is to evaluate the safety and tolerability of bemarituzumab plus 5-fluorouracil, leucovorin, and oxaliplatin (mFOLFOX6)...

Enrolling
Gastric Cancer
Gastroesophageal Junction Adenocarcinoma
Other: Placebo
Drug: Nivolumab

This study is researching an experimental drug called REGN3767, also known as fianlimab (R3767), when combined with another medication called REGN281...

Enrolling
Melanoma
Drug: Cemiplimab
Drug: Placebo

The purpose of the study is to assess the efficacy and safety of darolutamide in combination with standard androgen deprivation therapy (ADT) in pati...

Active, not recruiting
Prostatic Neoplasms
Other: Androgen deprivation therapy (ADT)
Drug: Placebo

This study is designed to assess the efficacy and safety of datopotamab deruxtecan (Dato-DXd) in combination with pembrolizumab versus pembrolizumab...

Enrolling
Metastatic Non Small Cell Lung Cancer
Drug: Carboplatin
Drug: Datopotamab Deruxtecan

The purpose of this study is to assess the efficacy and safety of pembrolizumab plus lenvatinib plus chemotherapy compared with pembrolizumab plus ch...

Enrolling
Metastatic Esophageal Squamous Cell Carcinoma
Drug: Paclitaxel
Drug: Lenvatinib

The purpose of this study is to determine the safety, tolerability, and preliminary efficacy of pembrolizumab/vibostolimab co-formulation (MK-7684A)...

Enrolling
Ovarian Neoplasms
Uterine Cervical Neoplasms
Drug: Docetaxel
Drug: Gemcitabine

The purpose of this study is to determine the safety and efficacy of belzutifan in combination with pembrolizumab and lenvatinib in multiple solid tu...

Enrolling
Carcinoma, Hepatocellular
Biliary Tract Neoplasms
Drug: Pembrolizumab
Drug: Lenvatinib

This study is designed to assess the efficacy and safety of datopotamab deruxtecan (Dato-DXd) in combination with pembrolizumab versus pembrolizumab...

Enrolling
Metastatic Non Small Cell Lung Cancer
Drug: Datopotamab Deruxtecan
Drug: Pembrolizumab

The purpose of this study is to compare pembrolizumab (MK-3475) in combination with sacituzumab govitecan with pembrolizumab alone with respect to pr...

Enrolling
Carcinoma, Non-Small-Cell Lung
Biological: Pembrolizumab
Biological: Sacituzumab Govitecan

Substudy 02B is part of a larger research study that is testing experimental treatments for melanoma, a type of skin cancer. The larger study is the...

Enrolling
Melanoma
Drug: Lenvatinib
Biological: Vibostolimab

Trial sponsors

Merck Sharp & Dohme (MSD) logo
Daiichi Sankyo logo
Regeneron Pharmaceuticals logo
Amgen logo
Bayer logo
Nektar Therapeutics logo
Roche logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems